Literature DB >> 8541254

Glucose metabolic correlates of continuous performance test performance in adults with a history of infantile autism, schizophrenics, and controls.

B V Siegel1, K H Nuechterlein, L Abel, J C Wu, M S Buchsbaum.   

Abstract

Twenty-five schizophrenic patients, fourteen adults with a history of infantile autism, and twenty normal controls performed a test of sustained attention, the degraded stimulus continuous performance test (CPT), during the 35 minute 18-fluoro-2-deoxyglucose uptake period preceding positron emission tomographic (PET) scan acquisition. This is the first analysis comparing correlations between glucose metabolic rate (GMR) for selected regions and CPT performance. CPT performance differed in controls and schizophrenics, but autistics did not differ from either group. In controls and schizophrenic patients, task performance correlated with GMR in medial superior frontal gyrus and lateral inferior temporal gyrus, suggesting that activation of those regions is important in the normal performance of the task and that damage to those regions, which also showed low GMR in schizophrenics, contributes to the attentional dysfunction in schizophrenia. Also, schizophrenics showed negative correlations of task performance with anterior cingulate activity suggesting that overactivity of that region, which is involved in mental effort and whose GMR was low in our larger study of schizophrenia, impairs task performance in schizophrenics. Autistic patients showed negative correlations of medial frontal cortical GMR with attentional performance, suggesting that neuronal inefficiency in that region may contribute to poor performance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8541254     DOI: 10.1016/0920-9964(95)00033-i

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  18 in total

Review 1.  [One decade of functional imaging in schizophrenia research. From visualisation of basic information processing steps to molecular-genetic oriented imaging].

Authors:  H Tost; A Meyer-Lindenberg; M Ruf; T Demirakça; O Grimm; F A Henn; G Ende
Journal:  Radiologe       Date:  2005-02       Impact factor: 0.635

2.  Inhibitory control in high-functioning autism: decreased activation and underconnectivity in inhibition networks.

Authors:  Rajesh K Kana; Timothy A Keller; Nancy J Minshew; Marcel Adam Just
Journal:  Biol Psychiatry       Date:  2006-11-29       Impact factor: 13.382

Review 3.  The elusive nature of executive functions: a review of our current understanding.

Authors:  María Beatriz Jurado; Mónica Rosselli
Journal:  Neuropsychol Rev       Date:  2007-09-05       Impact factor: 7.444

4.  Positron emission tomography assessment of cerebral glucose metabolic rates in autism spectrum disorder and schizophrenia.

Authors:  Serge A Mitelman; Marie-Cecile Bralet; M Mehmet Haznedar; Eric Hollander; Lina Shihabuddin; Erin A Hazlett; Monte S Buchsbaum
Journal:  Brain Imaging Behav       Date:  2018-04       Impact factor: 3.978

5.  Social Attention, Joint Attention and Sustained Attention in Autism Spectrum Disorder and Williams Syndrome: Convergences and Divergences.

Authors:  Giacomo Vivanti; Peter A J Fanning; Darren R Hocking; Stephanie Sievers; Cheryl Dissanayake
Journal:  J Autism Dev Disord       Date:  2017-06

6.  Functional dysconnectivity in schizophrenia associated with attentional modulation of motor function.

Authors:  Garry D Honey; Edith Pomarol-Clotet; Philip R Corlett; Rebekah A E Honey; Peter J McKenna; Edward T Bullmore; Paul C Fletcher
Journal:  Brain       Date:  2005-09-23       Impact factor: 13.501

7.  Resting neural activity distinguishes subgroups of schizophrenia patients.

Authors:  Dolores Malaspina; Jill Harkavy-Friedman; Cheryl Corcoran; Lilianne Mujica-Parodi; David Printz; Jack M Gorman; Ronald Van Heertum
Journal:  Biol Psychiatry       Date:  2004-12-15       Impact factor: 13.382

8.  Middle and inferior temporal gyrus gray matter volume abnormalities in chronic schizophrenia: an MRI study.

Authors:  Toshiaki Onitsuka; Martha E Shenton; Dean F Salisbury; Chandlee C Dickey; Kiyoto Kasai; Sarah K Toner; Melissa Frumin; Ron Kikinis; Ferenc A Jolesz; Robert W McCarley
Journal:  Am J Psychiatry       Date:  2004-09       Impact factor: 18.112

9.  Preattentional and attentional cognitive deficits as targets for treating schizophrenia.

Authors:  David L Braff; Gregory A Light
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

10.  Auditory attention in autism spectrum disorder: An exploration of volumetric magnetic resonance imaging findings.

Authors:  Sanam J Lalani; Tyler C Duffield; Haley G Trontel; Erin D Bigler; Tracy J Abildskov; Alyson Froehlich; Molly B D Prigge; Brittany G Travers; Jeffrey S Anderson; Brandon A Zielinski; Andrew Alexander; Nicholas Lange; Janet E Lainhart
Journal:  J Clin Exp Neuropsychol       Date:  2017-10-26       Impact factor: 2.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.